FRIEDMAN PAUL A sold MDGL
December 10, 2025 · Form 4 insider transaction
FRIEDMAN PAUL A sold 160 shares of Madrigal Pharmaceuticals, Inc. at $555.39 per share, a transaction worth $88.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
160
Price
$555.39
Total value
$88.9K
InsiderFRIEDMAN PAUL A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 10, 2025
Filing dateDecember 12, 2025
Shares owned after187,164
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.